Medical Director, Hereditary Cancer & High-Risk Program

About the role

The Medical Director of the Hereditary Cancer and High-Risk Program is a physician leader responsible for the development, oversight, and expansion of a comprehensive program dedicated to identifying and managing individuals at elevated risk for cancer.

Responsibilities

• Provide direct clinical oversight of the hereditary cancer and high-risk clinic, ensuring high-quality, patient-centered care for individuals with increased cancer risk due to family history, genetic predisposition, or other risk factors.
• Guide the development of individualized screening and risk-reduction strategies, incorporating the latest evidence and national guidelines.
• Supervise and mentor advanced practice providers (APPs) and genetic counselors (GCs), fostering a collaborative and high-performing clinical environment.
• Lead the multidisciplinary team in establishing referral pathways, standardizing care, and expanding access to high-risk services.
• Develop and implement standardized clinical algorithms and care pathways for common hereditary cancer syndromes (e.g., BRCA-related cancers, Lynch syndrome, familial adenomatous polyposis).
• Work closely with a broad range of colleagues, including primary care providers, oncologists, surgeons, gastroenterologists, gynecologists, and other specialists, to build strong referral relationships and increase program visibility.
• Educate providers on appropriate referral criteria, genetic testing indications, and high-risk management strategies.
• Oversee day-to-day program operations in partnership with administrative leadership, including staffing models, clinic capacity planning, workflow optimization, and performance monitoring.
• Establish key performance indicators (KPIs) such as referral volume, genetic testing uptake, adherence to screening recommendations, and patient outcomes, using these metrics to guide program improvement.
• Foster a culture of innovation and academic excellence by identifying opportunities for clinical research and contributing to educational initiatives for providers, trainees, and patients.

Qualifications

• MD or DO with board certification in oncology, medical genetics, internal medicine, or a related field.
• Demonstrated expertise in hereditary cancer syndromes, cancer risk assessment, and preventive oncology.
• Experience working with or overseeing multidisciplinary teams, including APPs and genetic counselors.
• Proven track record in program development, clinical leadership, or service line growth.
• Strong understanding of genetic testing technologies, guidelines (e.g., NCCN), and risk management strategies.
• Eligibility for medical licensure in the relevant state.

Leadership Competencies

The ideal candidate is a strategic thinker who can translate vision into execution. They are highly collaborative, able to build trust across disciplines, and effective at influencing change within complex health systems. They bring a balance of clinical rigor and operational pragmatism, with a commitment to innovation and continuous improvement.

Measures of Success

• Growth and impact of the program, including increased identification of high-risk patients, expanded access to genetic counseling and testing, and improved adherence to evidence-based screening and prevention strategies.
• Strong provider engagement, well-established referral networks, high patient satisfaction, and contributions to research and education.